Rizwana Sproule - Kite Pharma Vice President - Regulatory Affairs

President

Dr. Rizwana F. Sproule Ph.D. is the Vice President Regulatory Affairs of the Company since January 2014. Prior to joining us Dr. Sproule held senior positions at Amgen Inc. a biopharmaceutical company including Executive Director Therapeutic Area Head for Oncology Global Regulatory Affairs from September 2011 to January 2014 and Director Global Regulatory Leader Global Regulatory Affairs from August 2008 to September 2011 since 2014.
Age 52
Tenure 10 years
Professional MarksPh.D
Phone310 824-9999
Webwww.kitepharma.com
Sproule received her B.Sc. with honors in Biochemistry and her Ph.D. in Chemistry from the University of Warwick, United Kingdom. She also held a postdoctoral research position at the Institute of Biotechnology, Cambridge University in the United Kingdom.

Kite Pharma Management Efficiency

Kite Pharma's management efficiency ratios could be used to measure how well Kite Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

PRESIDENT Age

John WallCadence Design Systems
53
Andy LarkinSummit Materials
N/A
Deon MacMillanSummit Materials
47
Michael BradySummit Materials
51
Thomas BeckSummit Materials
67
Mikel EvansSummit Materials
47
Noel RyanSummit Materials
N/A
Douglas RauhSummit Materials
55
CHINCHI TENGCadence Design Systems
58
Neil ZamanCadence Design Systems
49
Anne BenedictSummit Materials
46
Damian MurphySummit Materials
46
Surendra MandavaCadence Design Systems
59
Kevin GillSummit Materials
55
Brian HarrisSummit Materials
68
Martin LundCadence Design Systems
46
Charlie HuangCadence Design Systems
49
James CowieCadence Design Systems
53
Karli AndersonSummit Materials
51
Karl WatsonSummit Materials
53
Kite Pharma, Inc., a clinicalstage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. Kite Pharma (KITE) is traded on NASDAQ Exchange in USA and employs 184 people.

Management Performance

Kite Pharma Leadership Team

Elected by the shareholders, the Kite Pharma's board of directors comprises two types of representatives: Kite Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kite. The board's role is to monitor Kite Pharma's management team and ensure that shareholders' interests are well served. Kite Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kite Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ran Nussbaum, Independent Director
Jonathan Peacock, Independent Director
Shawn Tomasello, Chief Commercial Officer
Jian Irish, Senior Vice President - Supply Chain
Cynthia Butitta, CFO and COO
Franz Humer, Director
Timothy Moore, Executive Vice President - Technical Operations
Jeffrey Wiezorek, Vice President - Clinical Development
Ian Clark, Independent Director
Steven Ruchefsky, Independent Director
Joshua Kazam, Director
Helen Kim, Executive Vice President - Business Development
Helen MBA, Executive VP of Bus. Devel.
David Bonderman, Lead Independent Director
David Chang, Executive Vice President - Research and Development, Chief Medical Officer
Arie Belldegrun, Executive Chairman of the Board and Presidentident, CEO, Founder
Christine Cassiano, Senior Vice President - Corporate Communications and Investor Relations
Owen Witte, Director
Paul Jenkinson, CFO
Marc Better, VP of Translation Medicine
Farah Champsi, Independent Director
Roy Doumani, Independent Director
Rizwana Sproule, Vice President - Regulatory Affairs
Margo Roberts, Chief Scientific Officer

Kite Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kite Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Kite Stock

If you are still planning to invest in Kite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kite Pharma's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data